查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1751021

2025年全球人类原代细胞培养市场报告

Human Primary Cell Culture Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，人类原代细胞培养市场规模将快速成长。 2029年，该市场规模将成长至58.2亿美元，复合年增长率为11.3%。预测期内的成长归因于再生医学投资的增加、精准医疗应用的不断增长、政府对细胞研究的资助增加、政府支持力度的加强以及人类原代细胞培养在毒理学检测中的应用日益增多。预测期内的主要趋势包括：人工智慧 (AI) 在细胞培养分析中的整合、无血清和化学成分确定培养基的开发、细胞培养过程自动化程度的提高、器官晶片技术的兴起以及免疫疗法研究中对原代细胞日益增长的需求。

人们对细胞和基因疗法日益增长的关注预计将推动人类原代细胞培养市场的扩张。细胞和基因疗法是一种尖端治疗方法透过修改和替换遗传物质和细胞来解决疾病的分子根源。这种日益增长的兴趣背后的原因是人们希望它能够透过针对遗传疾病、罕见疾病和癌症的根本原因来提供持久甚至根治性的解决方案。人类原代细胞培养在开发这些治疗方法、製造病毒载体和测试基因编辑方法中起着关键作用。例如，2024 年 7 月，美国非营利组织美国基因和细胞治疗学会 (ASGCT) 报告称，第二季度美国启动了 76 项基因疗法临床试验。因此，人们对细胞和基因疗法日益增长的关注正在加速人类原代细胞培养市场的成长。

iPSC 和 ESC 技术将成体细胞和胚胎细胞重编程为多功能状态，使其能够分化为各种细胞类型，用于科学研究、治疗开发和疾病建模。例如，2024 年 7 月，印度生命科学和生物技术公司 BioServe Biotechnologies India Pvt Ltd. 推出了 REPROCELL 的先进干细胞产品线，以支持印度的研究和药物研发。这些产品包括专用细胞培养基、干细胞分化套件、3D 培养系统、药物研发工具等，透过 iPSC 和 ESC 创新促进再生医学和临床前研究。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人类原代细胞培养PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球人类原代细胞培养市场：成长率分析
  • 全球人类原代细胞培养市场表现：规模与成长，2019-2024
  • 全球人类原代细胞培养市场预测：规模与成长，2024-2029，2034年
  • 全球人类原代细胞培养总目标市场（TAM）

第六章市场区隔

  • 全球人类原代细胞培养市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 初代细胞
  • 试剂和补充剂
  • 装置
  • 初代细胞培养基
  • 其他耗材
  • 全球人类原代细胞培养市场：应用、效能及预测，2019-2024 年、2024-2029 年、2034 年
  • 药物研发
  • 开发治疗方法
  • 再生医学
  • 其他用途
  • 全球人类原代细胞培养市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 製药和生物技术公司
  • 合约研究组织（CRO）
  • 学术研究所
  • 全球人类原代细胞培养市场细分（初代细胞类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 人类真皮纤维母细胞（HDF）
  • 人类表皮角质细胞（HEK）
  • 间质干细胞（HMSC）
  • 人类内皮细胞
  • 人类造血细胞
  • 全球人类原代细胞培养市场试剂和补充剂细分（按类型、实际和预测），2019-2024 年、2024-2029 年、2034 年
  • 生长因子和细胞激素
  • 抗生素和抗真菌药物
  • 牛（FBS）
  • 缓衝液和化学品
  • 冷冻保存试剂
  • 全球人类原代细胞培养市场，按仪器类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 细胞培养箱
  • 生物安全柜
  • 离心机
  • 细胞计数器和分析仪
  • 显微镜
  • 全球人类原代细胞培养市场细分（初代细胞培养基类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 无血清培养基
  • 化学成分确定的培养基
  • 古典媒体
  • 无蛋白培养基
  • 客製化媒体
  • 全球人类原代细胞培养市场其他耗材细分市场（按类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • 培养皿和培养板
  • 烧瓶和瓶子
  • 移液管和吸头
  • 细胞过滤器和滤膜
  • 涂层培养表面

第七章 区域和国家分析

  • 全球人类原代细胞培养市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球人类原代细胞培养市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 人类原代细胞培养市场：竞争格局
  • 人类原代细胞培养市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • American Type Culture Collection Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • PromoCell GmbH
  • Krishgen Biosystems Private Limited
  • Cell Culture Company Limited Liability Company
  • HiMedia Laboratories Private Limited
  • 3H Biomedical Aktiebolag
  • ScienCell Research Laboratories Inc.
  • Cell Applications Incorporated
  • Life Technologies Private Limited
  • PELOBIOTECH Gesellschaft mit beschrankter Haftung
  • Amsbio Limited
  • AcceGen Biotechnology Limited Liability Company
  • Cell Biologics Incorporated
  • BI Biotech India Private Limited
  • Innoprot Sociedad Limitada
  • ZenBio Incorporated

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年人类原代细胞培养市场：提供新机会的国家
  • 2029年人类原代细胞培养市场：细分领域带来新机会
  • 2029年人类原代细胞培养市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r34874

Human primary cell culture refers to the process of isolating cells directly from human tissues such as blood or bone marrow and maintaining them in a controlled environment for research or therapeutic use. These cultures offer a more accurate reflection of in vivo biological conditions compared to immortalized cell lines, making them highly valuable for scientific and medical applications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main product types in human primary cell culture include primary cells, reagents and supplements, instruments, primary cell culture media, and other related products. Primary cells are directly extracted from living tissues and are commonly used in research, drug testing, and various medical studies. Applications of human primary cell culture span drug discovery, therapy development, regenerative medicine, and more. These products and technologies serve a diverse range of end users, including pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic and research institutions.

The human primary cell culture market research report is one of a series of new reports from The Business Research Company that provides human primary cell culture market statistics, including human primary cell culture industry global market size, regional shares, competitors with a human primary cell culture market share, detailed human primary cell culture market segments, market trends and opportunities, and any further data you may need to thrive in the human primary cell culture industry. This human primary cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human primary cell culture market size has grown rapidly in recent years. It will grow from $3.39 billion in 2024 to $3.79 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth during the historic period can be attributed to the increasing adoption of cell-based research, rising demand for personalized medicine, a growing emphasis on drug discovery, an enhanced focus on individualized treatment approaches, and the expanding applications of human primary cell culture in cancer research.

The human primary cell culture market size is expected to see rapid growth in the next few years. It will grow to $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth during the forecast period can be attributed to rising investments in regenerative medicine, increased use in precision medicine, growing government funding for cell-based research, enhanced governmental support, and the expanding use of human primary cell culture in toxicology testing. Key trends anticipated in the forecast period include the integration of artificial intelligence (AI) in cell culture analysis, the development of serum-free and chemically defined media, increasing automation in cell culture processes, the emergence of organ-on-a-chip technology, and the growing demand for primary cells in immunotherapy research.

The rising emphasis on cell and gene therapies is anticipated to drive the expansion of the human primary cell culture market. Cell and gene therapies are cutting-edge treatments that involve modifying or replacing genetic material or cells to address diseases at their molecular roots. This growing interest is fueled by the promise of these therapies to offer long-lasting or even curative solutions for genetic disorders, rare diseases, and cancers by targeting their underlying causes. Human primary cell cultures play a vital role in developing these therapies, producing viral vectors, and testing gene-editing approaches. For example, in July 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based nonprofit organization, reported that 76 gene therapy trials were launched in the United States in Q2 2024 a 25% rise compared to the first quarter. As a result, the increasing focus on cell and gene therapies is accelerating the growth of the human primary cell culture market.

Leading companies in the human primary cell culture market are investing in the development of advanced technologies such as induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) to boost research capabilities, drug discovery, and regenerative medicine efforts. iPSC and ESC technologies involve reprogramming adult or embryonic cells into pluripotent states, enabling them to differentiate into various cell types for use in scientific research, therapy development, and disease modeling. For instance, in July 2024, BioServe Biotechnologies India Pvt Ltd., an India-based life sciences and biotechnology company, introduced a new range of advanced stem cell products from REPROCELL to support research and drug discovery in India. These offerings include specialized cell culture media, stem cell differentiation kits, 3D culture systems, and drug discovery tools advancing regenerative medicine and preclinical studies powered by iPSC and ESC innovations.

In April 2023, AnaBios Corporation, a US-based contract research organization (CRO), announced the acquisition of Cell Systems Corporation for an undisclosed sum. Through this acquisition, AnaBios seeks to broaden its portfolio of biologically relevant human tissues and primary cells, enhancing research capabilities in cell biology and drug discovery. Cell Systems Corporation, also based in the US, is a provider of human primary cells, specialized cell culture media, and related reagents.

Major players in the human primary cell culture market are Thermo Fisher Scientific Inc., Merck & Co. Inc., Lonza Group AG, STEMCELL Technologies Inc., American Type Culture Collection, PromoCell GmbH, Krishgen Biosystems Private Limited, Cell Culture Company Limited Liability Company, HiMedia Laboratories Private Limited, 3H Biomedical Aktiebolag, ScienCell Research Laboratories Inc., Cell Applications Incorporated, Life Technologies Private Limited, PELOBIOTECH Gesellschaft mit beschrankter Haftung, Amsbio Limited, AcceGen Biotechnology Limited Liability Company, Cell Biologics Incorporated, BI Biotech India Private Limited, Innoprot Sociedad Limitada, ZenBio Incorporated, Evercyte GmbH, Cell Systems Corporation, Cytion GmbH, Kosheeka Private Limited.

North America was the largest region in the human primary cell culture market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in human primary cell culture report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human primary cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human primary cell culture market consists of revenues earned by entities by providing services such as cell isolation, culture media development, cryopreservation, cell characterization, and quality control testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The human primary cell culture market also includes sales of culture media, reagents, bioreactors, incubators, cell storage systems, and imaging systems used in regenerative medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Primary Cell Culture Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human primary cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human primary cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human primary cell culture market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Primary Cells; Reagents And Supplements; Instruments; Primary Cell Culture Media; Other Consumables
  • 2) By Applications: Drug Discovery; Therapy Development; Regenerative Medicine; Other Applications
  • 3) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs); Academic And Research Institutions
  • Subsegments:
  • 1) By Primary Cells: Human Dermal Fibroblasts (HDF); Human Epidermal Keratinocytes (HEK); Human Mesenchymal Stem Cells (HMSC); Human Endothelial Cells; Human Hematopoietic Cells
  • 2) By Reagents And Supplements: Growth Factors And Cytokines; Antibiotics And Antimycotics; Fetal Bovine Serum (FBS); Buffers And Chemicals; Cryopreservation Reagents
  • 3) By Instruments: Cell Culture Incubators; Biosafety Cabinets; Centrifuges; Cell Counters And Analyzers; Microscopes
  • 4) By Primary Cell Culture Media: Serum-Free Media; Chemically Defined Media; Classical Media; Protein-Free Media; Custom Media
  • 5) By Other Consumables: Culture Dishes And Plates; Flasks And Bottles; Pipettes And Tips; Cell Strainers And Filters; Coated Culture Surfaces
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck & Co. Inc.; Lonza Group AG; STEMCELL Technologies Inc.; American Type Culture Collection
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Primary Cell Culture Market Characteristics

3. Human Primary Cell Culture Market Trends And Strategies

4. Human Primary Cell Culture Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Human Primary Cell Culture Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Human Primary Cell Culture PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Human Primary Cell Culture Market Growth Rate Analysis
  • 5.4. Global Human Primary Cell Culture Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Human Primary Cell Culture Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Human Primary Cell Culture Total Addressable Market (TAM)

6. Human Primary Cell Culture Market Segmentation

  • 6.1. Global Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Primary Cells
  • Reagents And Supplements
  • Instruments
  • Primary Cell Culture Media
  • Other Consumables
  • 6.2. Global Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery
  • Therapy Development
  • Regenerative Medicine
  • Other Applications
  • 6.3. Global Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic And Research Institutions
  • 6.4. Global Human Primary Cell Culture Market, Sub-Segmentation Of Primary Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Human Dermal Fibroblasts (HDF)
  • Human Epidermal Keratinocytes (HEK)
  • Human Mesenchymal Stem Cells (HMSC)
  • Human Endothelial Cells
  • Human Hematopoietic Cells
  • 6.5. Global Human Primary Cell Culture Market, Sub-Segmentation Of Reagents And Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Growth Factors And Cytokines
  • Antibiotics And Antimycotics
  • Fetal Bovine Serum (FBS)
  • Buffers And Chemicals
  • Cryopreservation Reagents
  • 6.6. Global Human Primary Cell Culture Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Culture Incubators
  • Biosafety Cabinets
  • Centrifuges
  • Cell Counters And Analyzers
  • Microscopes
  • 6.7. Global Human Primary Cell Culture Market, Sub-Segmentation Of Primary Cell Culture Media, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum-Free Media
  • Chemically Defined Media
  • Classical Media
  • Protein-Free Media
  • Custom Media
  • 6.8. Global Human Primary Cell Culture Market, Sub-Segmentation Of Other Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Culture Dishes And Plates
  • Flasks And Bottles
  • Pipettes And Tips
  • Cell Strainers And Filters
  • Coated Culture Surfaces

7. Human Primary Cell Culture Market Regional And Country Analysis

  • 7.1. Global Human Primary Cell Culture Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Human Primary Cell Culture Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Human Primary Cell Culture Market

  • 8.1. Asia-Pacific Human Primary Cell Culture Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Human Primary Cell Culture Market

  • 9.1. China Human Primary Cell Culture Market Overview
  • 9.2. China Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Human Primary Cell Culture Market

  • 10.1. India Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Human Primary Cell Culture Market

  • 11.1. Japan Human Primary Cell Culture Market Overview
  • 11.2. Japan Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Human Primary Cell Culture Market

  • 12.1. Australia Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Human Primary Cell Culture Market

  • 13.1. Indonesia Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Human Primary Cell Culture Market

  • 14.1. South Korea Human Primary Cell Culture Market Overview
  • 14.2. South Korea Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Human Primary Cell Culture Market

  • 15.1. Western Europe Human Primary Cell Culture Market Overview
  • 15.2. Western Europe Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Human Primary Cell Culture Market

  • 16.1. UK Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Human Primary Cell Culture Market

  • 17.1. Germany Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Human Primary Cell Culture Market

  • 18.1. France Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Human Primary Cell Culture Market

  • 19.1. Italy Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Human Primary Cell Culture Market

  • 20.1. Spain Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Human Primary Cell Culture Market

  • 21.1. Eastern Europe Human Primary Cell Culture Market Overview
  • 21.2. Eastern Europe Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Human Primary Cell Culture Market

  • 22.1. Russia Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Human Primary Cell Culture Market

  • 23.1. North America Human Primary Cell Culture Market Overview
  • 23.2. North America Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Human Primary Cell Culture Market

  • 24.1. USA Human Primary Cell Culture Market Overview
  • 24.2. USA Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Human Primary Cell Culture Market

  • 25.1. Canada Human Primary Cell Culture Market Overview
  • 25.2. Canada Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Human Primary Cell Culture Market

  • 26.1. South America Human Primary Cell Culture Market Overview
  • 26.2. South America Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Human Primary Cell Culture Market

  • 27.1. Brazil Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Human Primary Cell Culture Market

  • 28.1. Middle East Human Primary Cell Culture Market Overview
  • 28.2. Middle East Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Human Primary Cell Culture Market

  • 29.1. Africa Human Primary Cell Culture Market Overview
  • 29.2. Africa Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Human Primary Cell Culture Market Competitive Landscape And Company Profiles

  • 30.1. Human Primary Cell Culture Market Competitive Landscape
  • 30.2. Human Primary Cell Culture Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. American Type Culture Collection Overview, Products and Services, Strategy and Financial Analysis

31. Human Primary Cell Culture Market Other Major And Innovative Companies

  • 31.1. PromoCell GmbH
  • 31.2. Krishgen Biosystems Private Limited
  • 31.3. Cell Culture Company Limited Liability Company
  • 31.4. HiMedia Laboratories Private Limited
  • 31.5. 3H Biomedical Aktiebolag
  • 31.6. ScienCell Research Laboratories Inc.
  • 31.7. Cell Applications Incorporated
  • 31.8. Life Technologies Private Limited
  • 31.9. PELOBIOTECH Gesellschaft mit beschrankter Haftung
  • 31.10. Amsbio Limited
  • 31.11. AcceGen Biotechnology Limited Liability Company
  • 31.12. Cell Biologics Incorporated
  • 31.13. BI Biotech India Private Limited
  • 31.14. Innoprot Sociedad Limitada
  • 31.15. ZenBio Incorporated

32. Global Human Primary Cell Culture Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Primary Cell Culture Market

34. Recent Developments In The Human Primary Cell Culture Market

35. Human Primary Cell Culture Market High Potential Countries, Segments and Strategies

  • 35.1 Human Primary Cell Culture Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Human Primary Cell Culture Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Human Primary Cell Culture Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34874_Human_Primary_Cell_Culture_GMR_2025